Global Death Care 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031The global Death Care market size was valued at US$ 139380 million in 2024 and is forecast to a readjusted size of USD 198940 million by 2031 with a CAGR of 5.3% during review period.
Death care includes companies who provide death-related goods and services such as funerals, burials, cremations, coffins, lots in cemeteries, headstones and memorials. The Death Care industry is divided into three segments: the ceremony and tribute (funeral or memorial service); the disposition of remains through cremation or burial (internment); and memorialization in the form of monuments, marker inscriptions or memorial art.
Global death care main players include Service Corporation International, Batesville, Chemed Corp, Matthews International Corporation, StoneMor Partners, Wilbert Funeral Services, Carriage Services, etc., totally accounting for about 5% of the market. Asia-Pacific is the largest market, with a share over 35%. As for the types of products, it can be divided into...Read more | USD 3,480.00 |
Global Deslanoside 麻豆原创 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031The global Deslanoside market size was valued at US$ 1.1 million in 2024 and is forecast to a readjusted size of USD 1.7 million by 2031 with a CAGR of 5.8% during review period.
Deslanoside is a cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation.
Global deslanoside main players include Beijing lingbao, Green Stone, Swapnroop Drugs and Pharmaceuticals, Push Bio, Sigma-Aldrich, Carbosynth, Bolise Co., Ltd., Shanghai Yuanye, etc. North America is the largest market, with a share over 49%. As for the types of products, it can be divided into 97%min deslanoside, 98%min deslanoside and others. The most common product is 97%min deslanoside, with a share over 58%. In terms of applications, it is widely used in pharmaceutical factory and research institute. Pharmaceutical factory is the largest application, holding a share over 99%....Read more | USD 3,480.00 |
Global Human Oocyte Cryopreservation 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031The global Human Oocyte Cryopreservation market size was valued at US$ 93.6 million in 2024 and is forecast to a readjusted size of USD 241 million by 2031 with a CAGR of 14.6% during review period.
Human oocyte cryopreservation (egg freezing) is a procedure to preserve female eggs (oocytes). The eggs are extracted, frozen and stored. The purpose of the procedure is to give women the option of thawing, fertilizing and transplanting the eggs into the uterus as embryos to promote future pregnancy.
Oocyte cryopreservation refers to the technology of cooling human oocytes and storing them in liquid nitrogen (generally stored in liquid nitrogen at -196掳C), resuscitating (thawing) them when needed, and ensuring that the oocytes are alive and functioning normally. It is a derivative technology of assisted reproductive technology, mainly used to treat infertility and preserve female fertility.
The driving factors of the oocyte cryopreservation market mainly include the...Read more | USD 3,480.00 |
Global Direct-to-consumer Genetic Testing 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031The global Direct-to-consumer Genetic Testing market size was valued at US$ 1927 million in 2024 and is forecast to a readjusted size of USD 6229 million by 2031 with a CAGR of 18.5% during review period.
Direct-to-consumer (DTC) genetic testing is a type of genetic test that is accessible directly to the consumer without having to go through a health care professional. Usually, to obtain a genetic test, health care professionals (such as doctors) acquire their patient"s permission and then order the desired test. DTC genetic tests, however, allow consumers to bypass this process and order DNA tests themselves.
Global direct-to-consumer genetic testing main players include 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 60%. As for the types of products, it can be divided into diagnostic screening, preimplantation genetic diagnosis (PGD) and...Read more | USD 3,480.00 |
Global Corticosteroids API 麻豆原创 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031The global Corticosteroids API market size was valued at US$ 2491 million in 2024 and is forecast to a readjusted size of USD 3721 million by 2031 with a CAGR of 6.0% during review period.
Corticosteroids are a class of hormones that are naturally produced in the body or can be artificially synthesized for medicinal use. They have potent anti-inflammatory and immunosuppressive properties, and they are commonly used to treat a variety of medical conditions, including allergies, asthma, arthritis, and certain autoimmune disorders.
Global core manufacturers of Corticosteroids API include Pfizer CentreOne, EUROAPI and GlaxoSmithKline. The top three companies have a market share of about 28%. China is the world's largest market for Corticosteroids API with a market share of about 44%, followed by Europe and North America with a market share of 23% and 10%, respectively. In terms of product type, Dexamethasone Series is the largest segment, with a market share of...Read more | USD 3,480.00 |
0 items USD 0.00
Printer version
Send by email
